Format

Send to

Choose Destination
Contraception. 2009 Nov;80(5):457-62. doi: 10.1016/j.contraception.2009.04.003. Epub 2009 May 14.

Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain.

Author information

1
University Health Centre of La Chana, Health District of Granada, Andalusian Health Service, Granada 18015, Spain. l.arribas@terra.es

Abstract

BACKGROUND:

User profile, continuation rate, reasons for discontinuation, problems during insertion and removal, and effectiveness of an etonogestrel subdermal contraceptive implant (ESCI) were assessed.

STUDY DESIGN:

A follow-up of 372 women 3 years after insertion of an ESCI performed by family physicians in Granada, Spain, by means of consultations, examination of medical records and telephone interviews.

RESULTS:

Data were available for 356 (95.7%) women. The average age was 27.2 years, and 159 (42.7%) were nulliparous. Continuation rates were 91.0% at 1 year, 74.7% at 2 years and 65.1% at 2 years and 9 months. The main reasons for discontinuation were excessive bleeding (44, 12.4%), wish to become pregnant (44, 12.4%) and side effects not related to menstruation (21, 5.9%). However, 141 (39.6%) received a second implant when the first one expired. No pregnancy occurred in 893.4 women-years.

CONCLUSIONS:

Family physicians can achieve excellent results with the ESCI. It should be included in the range of contraceptives offered by primary care physicians.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center